Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials
Background. Diverticular disease treatment is limited to fibres, antibiotics, and surgery. There is conflicting evidence on mesalazine benefits and harms. Aim. We systematically reviewed current evidence on benefits and harms of mesalazine versus all other treatments in people with diverticular dise...
Saved in:
Main Authors: | Andrea Iannone, Marinella Ruospo, Germaine Wong, Michele Barone, Mariabeatrice Principi, Alfredo Di Leo, Giovanni F. M. Strippoli |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Canadian Journal of Gastroenterology and Hepatology |
Online Access: | http://dx.doi.org/10.1155/2018/5437135 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Surgery for diverticular peritonitis
by: Savvas Papagrigoriadis, et al.
Published: (2025-02-01) -
T Helper Lymphocyte and Mast Cell Immunohistochemical Pattern in Nonceliac Gluten Sensitivity
by: Giuseppe Losurdo, et al.
Published: (2017-01-01) -
Diverticular Pylephlebitis and Polymicrobial Septicemia
by: Pradhum Ram, et al.
Published: (2017-01-01) -
The role of gut microbiota in the pathogenesis of diverticular disease: where are we now?
by: Antonio Tursi, et al.
Published: (2024-12-01) -
Mesalazine use tactics in the ulcerative colitis patients
by: A. V. Korolev, et al.
Published: (2013-03-01)